Efficacy and safety of thrice-weekly insulin degludec in elderly patients with type 2 diabetes
Not Applicable
- Conditions
- Type 2 diabetes
- Registration Number
- JPRN-UMIN000022239
- Lead Sponsor
- St. Marianna University School ofMedicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
The exclusion criteria were the following absolute indications for insulin treatment: 1) an insulin-dependent state, 2) diabetic coma, 3) hyperglycemia complicated by severe liver or kidney disease, 4) serious infection, trauma, or major surgery, 5) intravenous alimentation. Patients who had no difficulty performing self-injection of insulin were also excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Glycemic controlassessed by continuous glucose monitoring over 7 days
- Secondary Outcome Measures
Name Time Method The percent duration of hypo- (<70 mg/dL and hyper- (>200 mg/dL) glycemia